Illumina announces next generation of iSelect custom genotyping products

Illumina, Inc. (NASDAQ:ILMN) today announced its next generation of iSelect custom genotyping products that allow researchers to design custom arrays containing from 3,000 up to 1,000,000 markers, with the flexibility to add supplemental content to their array designs. The additional marker and add-on content capabilities enable researchers to draw on the latest advances from genome-wide association studies, next-generation whole-genome sequencing, and exome sequencing studies for variant confirmation, fine mapping, and target validation. Next generation iSelect also delivers the flexibility in plexity, pricing, and content that applied markets need to transition to the latest genomic tools.

"Next generation iSelect custom genotyping will facilitate more data generation, and at a lower price that will make our Infinium® assay available to a market segment not able to access it previously," said Christian Henry, General Manager of Life Sciences at Illumina. "We are especially excited about the product's new add-on content capabilities, which will allow customers to design new content for their existing custom arrays using markers found through ongoing GWAS and sequencing efforts. This feature is unique to Illumina's custom high-density arrays and provides a significant benefit to customers who want to add newly discovered content after the initial design period is completed."

iSelect custom genotyping arrays provide:

  • Accurate and powerful data. The proven Infinium assay enables specificity and selectivity for more robust genotype calls and industry-leading data quality.
  • Flexible design. Researchers can design arrays with content from any source and any species, as well as add content after the initial design is complete.
  • Relevant custom content. Illumina's proprietary Assay Design Tool allows researchers to design arrays with the most relevant SNPs, CNVs, and insertions/deletions.
  • Fast and cost-effective genotyping. Illumina's 24-sample iSelect format allows researchers to process thousands of samples per week, decreasing time to results.

iSelect products are available for order immediately.

Source:

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Illumina, Inc.. (2019, June 20). Illumina announces next generation of iSelect custom genotyping products. News-Medical. Retrieved on April 26, 2024 from https://www.news-medical.net/news/20110110/Illumina-announces-next-generation-of-iSelect-custom-genotyping-products.aspx.

  • MLA

    Illumina, Inc.. "Illumina announces next generation of iSelect custom genotyping products". News-Medical. 26 April 2024. <https://www.news-medical.net/news/20110110/Illumina-announces-next-generation-of-iSelect-custom-genotyping-products.aspx>.

  • Chicago

    Illumina, Inc.. "Illumina announces next generation of iSelect custom genotyping products". News-Medical. https://www.news-medical.net/news/20110110/Illumina-announces-next-generation-of-iSelect-custom-genotyping-products.aspx. (accessed April 26, 2024).

  • Harvard

    Illumina, Inc.. 2019. Illumina announces next generation of iSelect custom genotyping products. News-Medical, viewed 26 April 2024, https://www.news-medical.net/news/20110110/Illumina-announces-next-generation-of-iSelect-custom-genotyping-products.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Illumina donates more than 95,000 human genetic variants to ClinVar database